About Finoso Pharma Private Limited
Data last updated: 10 January 2026
Finoso Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Vivimed Labs Limited. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 18 August 2009, the company has been in operation for over 17 years.
Registered with ROC Hyderabad under CIN U24231AP2009PTC064774.
Capital: an authorised share capital of ₹3.5 Cr and a paid-up capital of ₹3.02 Cr. It is led by directors including Aparna Bidarkar and Kunapareddy Devi Prasad.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Sp Biotech Park – Phase – I Block – I Turkapally Shameerpet Mandal, Hyderabad, Telangana, India – 500078.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.69 Cr, a decline of 7% compared to the previous year.
The company has a workforce of approximately 15 employees as per the latest available data. It operates as a subsidiary of Vivimed Labs Limited.
The company is associated with 2 brands - Finoso Pharma, Vivimed Labs. As per MCA filings, the company has open charges of ₹4.5 Cr and satisfied charges of ₹2.45 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website finoso.com.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered AddressSp Biotech Park – Phase – I Block – I Turkapally Shameerpet Mandal, Hyderabad, Telangana, India – 500078
-
IndustryPharma, Pharma Contract R&D
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Finoso Pharma Private Limited
Finoso Pharma Private Limited has one previous CIN (Corporate Identification Number): U24231AP2009PTC064774. The current CIN is U24231TG2009PTC064774, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TG2009PTC064774 | Current |
| U24231AP2009PTC064774 | Previous |
Associated Brands with Finoso Pharma Private Limited
Finoso Pharma Private Limited operates two associated brands: Finoso Pharma and Vivimed Labs. These brands represent Finoso Pharma Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Offers pharmaceutical formulation research, development, manufacturing, and business services. | finoso.com | |
| Active pharmaceutical ingredients, formulations, and specialty chemicals are manufactured. | vivimedlabs.com |
Competitors & Alternatives of Finoso Pharma Private Limited
Brands and companies operating in the same space as Finoso Pharma Private Limited include Concord Biotech, WuXi AppTec, Almac Group and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
WuXi AppTec
|
Provider of CRO and CDMO services | Shanghai, China, China | 2000 |
Almac Group
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
ANI Pharmaceuticals
|
Branded and generic prescription drugs are developed, manufactured, and marketed. | Baudette, United States, United States | 1996 |
Aptar
|
Regulatory support, brand differentiation, and prototyping services are provided. | Crystal Lake, United States, United States | 1992 |
Indoco Remedies
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
CHEPLAPHARM
|
Branded pharmaceutical products are developed, marketed, and distributed globally. | Mesekenhagen, Germany, Germany | 1998 |
Red Nucleus
|
Advisory, scientific, and medical communications provided for pharmaceutical industry. | Yardley, United States, United States | 2014 |
Ipsen
|
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | - | 1929 |
Eurofins Scientific
|
Laboratory testing and contract research services are provided globally. | Luxembourg, Luxembourg, Luxembourg | 1987 |
Business Activity of Finoso Pharma Private Limited
Finoso Pharma Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details for Finoso Pharma Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Finoso Pharma Private Limited
Finoso Pharma Private Limited is currently managed by 3 directors, with 10 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Aparna Bidarkar
Also directs:
Lattice Projex Private Limited
|
Director | 05 Jun 2025 | 1 Years 2 Months | Current |
| Kunapareddy Devi Prasad | Additional Director | 08 Mar 2024 | 2 Years 5 Months | Current |
| Phaninder Nath Peta Sonti | Additional Director | 16 Jul 2025 | 1 Years 1 Months | Current |
Financials of Finoso Pharma Private Limited FY 2025 filings available
Finoso Pharma Private Limited reported revenue of ₹17.69 Cr (down 7.00% YoY) for FY 2025.
Ten-year financial statements for Finoso Pharma Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Finoso Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2014 | State Bank of India | ₹4.5 Cr | Open |
| 28 Oct 2009 | State Bank of India | ₹2.45 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Finoso Pharma Private Limited
View historical data on people associated with Finoso Pharma Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Finoso Pharma Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Finoso Pharma Private Limited
GST registrations and filing compliance for Finoso Pharma Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Finoso Pharma Private Limited
Credit ratings, litigation, and regulatory alerts for Finoso Pharma Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Finoso Pharma Private Limited
MSME payment history for Finoso Pharma Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Finoso Pharma Private Limited
Corporate group structure for Finoso Pharma Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Finoso Pharma Private Limited
MCA filings and documents for Finoso Pharma Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Finoso Pharma Private Limited
Frequently Asked Questions about Finoso Pharma Private Limited
Finoso Pharma Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 18 August 2009 (17+ years old) and is registered under CIN U24231TG2009PTC064774. The company has 15 employees.
Finoso Pharma Private Limited reported revenue of ₹17.69 Cr for FY 2025 (down 7.00% YoY).
The current directors of Finoso Pharma Private Limited are:
- Aparna Bidarkar - Director
- Kunapareddy Devi Prasad - Additional Director
- Phaninder Nath Peta Sonti - Additional Director
The primary industry of Finoso Pharma Private Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.
Finoso Pharma Private Limited can be reached at the registered office: Sp Biotech Park – Phase – I Block – I Turkapally Shameerpet Mandal, Hyderabad, Telangana, India – 500078, or through the website finoso.com.
The authorised capital is ₹3.5 Cr, and the paid-up capital is ₹3.02 Cr.